Comparison of effectiveness and drug cost between dipeptidyl peptidase‐4 inhibitor and biguanide as the first‐line anti‐hyperglycaemic medication among Japanese working generation with type 2 diabetes [Book Review]

Abstract This article has no associated abstract. (fix it)
Keywords No keywords specified (fix it)
Categories No categories specified
(categorize this paper)
DOI 10.1111/jep.13171
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

Our Archive

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 43,883
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

NICE Rejoinder.J. Harris - 2007 - Journal of Medical Ethics 33 (8):467-467.
Maximizing Local Effect of HIV Prevention Resources.Shin-Yi Wu, Deborah Cohen, Lu Shi & Thomas Farley - 2005 - Contagion: Journal of Violence, Mimesis, and Culture 2 (3):127-132.
Practice and Protocol Analyses of Cost- Effectiveness: An Inconvenient Distinction.Abraham Schwab - 2010 - Ethics in Biology, Engineering and Medicine 1 (3):187-197.


Added to PP index

Total views

Recent downloads (6 months)

How can I increase my downloads?


Sorry, there are not enough data points to plot this chart.

My notes

Sign in to use this feature